Matthew McTaggart

Broncus Medical, Inc.

Broncus Medical, Inc. is a well-funded, commercial stage company based in San Jose, CA. The Company's mission is to deliver navigation, diagnostic & therapeutic technologies to treat patients with lung disease. The Company has a comprehensive intellectual property portfolio with ~75 patents including those issued, licensed, and pending. Along with Broncus Medical's focus on technological advancements, it is committed to providing outstanding value to patients, medical professionals, investors and employees. Broncus Medical has commercialized and continues to develop innovative solutions for diagnosing and treating lung diseases. Physicians use LungPoint® Virtual Bronchoscopic Navigation Systems to plan bronchoscopic procedures and quickly and accurately maneuver to tumors in the lungs. LungPoint is a powerful platform for computer-assisted, image-guided bronchoscopic planning and navigation that is intuitive and easy to use. It provides a map and visual directions through the lung airways to a lung tumor. The unique 18 gauge FleXNeedle® coring needle enables peripheral sampling and access to hard-to-reach areas of the lungs. Now Broncus has developed Archimedes™ total lung access platform, including BTPNA - Bronchoscopic Trans-Parenchymal Nodule Access. The Archimedes System combines state-of-the-art nodule, vessel and airway mapping, pathway guidance and intra-operative fluoroscopy imaging - allowing never before biopsy and therapeutic access to any spot in the lung.